Jessica Hu and Gene Bio Medical Featured in EY Canada’s Pointing North 2026
Gene Bio Medical is pleased to share that CEO Jessica Hu and the company’s work in accessible diagnostics and Canadian healthcare innovation are featured in the 2026 edition of Pointing North, EY Canada’s national platform highlighting the people, ideas and technologies shaping Canada’s economic future.
The feature, “Strengthening Our Health Ecosystem, One Test at a Time,” explores Gene Bio Medical’s focus on translating diagnostic innovation into practical solutions for patients, pharmacists and healthcare providers. It also highlights the importance of accessible testing, resilient Canadian supply chains and connecting scientific development with real-world healthcare needs.
“Our purpose is simple: making high-quality testing available anytime, anywhere.” — Jessica Hu, CEO, Gene Bio Medical
Gene Bio Medical is a member of GBM Health Group, contributing diagnostics, research, development and biomanufacturing capabilities to the Group’s broader health innovation ecosystem.
Read the full Pointing North 2026 publication on EY.com:
https://www.ey.com/en_ca/pointing-north
Pointing North is an EY Canada publication. The publication cover is reproduced here for the purpose of identifying and linking to the featured publication. This announcement was prepared independently by Gene Bio Medical.